(Q44148387)

30 November 2017

title

Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia (English)

1 reference

respiratory syncytial virus pneumonia

30 November 2017

0 references

1 reference

2

1 reference

30 November 2017

Field K

1

1 reference

30 November 2017

Seymour JF

series ordinal

3

1 reference

30 November 2017

publication date

1 July 2002

1 reference

European Journal of Haematology

30 November 2017

published in

1 reference

30 November 2017

volume

69

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

54-57

1 reference

From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

An outbreak of respiratory syncytial virus in a bone marrow transplant center

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Severe respiratory syncytial virus pulmonary infection in a patient treated with fludarabine for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Respiratory viral infections in immunocompetent and immunocompromised persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Community respiratory virus infections in immunocompromised patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Community respiratory viruses in individuals with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

Infections in patients with chronic lymphocytic leukemia treated with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2002.02745.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1600-0609.2002.02745.X

1 reference

30 November 2017

1 reference